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Abstract
The delivery of drugs to specific neural targets faces two fundamental problems: (1) most drugs do not cross the blood-
brain barrier, and (2) those that do, spread to the entire brain. To date, there exists only one non-invasive methodology with
the potential to solve these problems: selective blood-brain barrier (BBB) opening using micro-bubble enhanced focused
ultrasound. We have recently developed a single-element 500-kHz spherical transducer ultrasound setup for targeted BBB
opening in the non-human primate that does not require simultaneous MRI monitoring. So far, however, the targeting
accuracy that can be achieved with this system has not been quantified systematically. In this paper, the accuracy of this
system was tested by targeting caudate nucleus and putamen of the basal ganglia in two macaque monkeys. The average
lateral targeting error of the system was ,2.5 mm while the axial targeting error, i.e., along the ultrasound path, was
,1.5 mm. We have also developed a real-time treatment monitoring technique based on cavitation spectral analysis. This
technique also allowed for delineation of a safe and reliable acoustic parameter window for BBB opening. In summary, the
targeting accuracy of the system was deemed to be suitable to reliably open the BBB in specific sub-structures of the basal
ganglia even in the absence of MRI-based verification of opening volume and position. This establishes the method and the
system as a potentially highly useful tool for brain drug delivery.
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Introduction
To date, there exists no non-invasive clinical method to deliver
drugs to specifically targeted brain regions mainly because of the
presence of the Blood-Brain Barrier (BBB) [1–2]. There are a
number of methods currently available such as intracranial
injections, mixing or attaching agents to BBB-modifying chemicals
as well as the chemical alteration of agents to be delivered through
endogenous transport systems [3]. However, these techniques are
either invasive, drug-specific or are plagued by very poor spatial
specificity. This is particularly problematic for deep sub-cortical
structures such as the basal ganglia because alternative invasive
approaches may damage not only the target structure, but also
overlying grey and white matter. A non-invasive method would be
highly useful not only for clinical use, but also for neuroscientists
trying to study the role of the basal ganglia in animal models of
neurological and neuropsychiatric disorders such as Parkinson’s,
Huntington’s Schizophrenia, Obsessive Compulsive Disorder and
addiction.
Here, we present recent advances in the development of a
focused ultrasound (FUS) method for targeted drug delivery in the
non-human primate, highlighting the ability of the method to
reliably target specific sub-structures of the basal ganglia. We show
that the method has a number of desirable features that make it
highly interesting not only for clinicians interested in delivering
therapeutic drugs to the basal ganglia, but also for neuroscientists
trying to manipulate the behavior of certain neuronal populations
to study their role in normal function and models of disease.
The method uses brief FUS pulses in combination with
systemically injected micro-bubbles to cause reversible increases
in the permeability of localized parts of the BBB. The BBB is a
selective barrier within the neurovascular unit formed by the
endothelial cells that line the cerebral microvessels. The BBB
hinders the effective systemic delivery to the brain of more than
98% of small-molecule drugs and nearly all large-molecule drugs
[3]. Mixing or attaching agents to BBB-modifying chemicals, and
the chemical alteration of agents enables them to be delivered
through endogenous transport systems [4] but those techniques
are not region specific. It is therefore a risky procedure, as it
increases the influx of therapeutic molecules throughout the brain.
The FUS-method locally increases the permeability of the BBB by
low shear stress caused by micro-bubbles oscillating between the
walls of brain capillaries in the focused ultrasound beam [5]. The
mechanical stress is believed to enable passive diffusion of
compounds that would not cross the intact BBB. This technique
has been proven capable of delivering compounds with a wide
range of size. Choi et al. [6], proved that 70 kDa Dextran was able
to be delivered using FUS and Wang et al. [7] delivered adeno-
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associated viruses (4 MDa) using the same technique. The
ultrasound procedure is completely non-invasive and can be
delivered through the intact skin and skull. The focusing of the
ultrasound prevents high pressures outside of the focus and hence
restricts the opening of the BBB to the ultrasound focus.
Therefore, the method is especially well suited to target deep
subcortical brain structures while leaving the overlying cortex
unaffected.
One of the main challenges in the development of the FUS
method for clinical use as well as the laboratory setting is to
maximize targeting accuracy while minimizing the time and effort
necessary for accurate targeting. Targeting accuracy is limited
primarily by the skull that causes aberrations of the ultrasound
beam. The discrepancy between the high speed of sound through
the skull and the low speed through the underlying brain tissue,
combined with a severe attenuation of ultrasound waves through
the skull bone, strongly distorts the beam shape especially at higher
frequencies [8]. Moreover, the trabecular layer of the skull induces
heterogeneities in both speed of sound and density that lead to
strong phase aberrations of the acoustic beam. At higher
frequencies the defocusing effect of the skull is more severe as
the wavelength tends to reach the size of local skull bone
heterogeneities (typical size of the trabeculae is around 1 mm).
The phase aberrations can be reduced by reducing the ultrasound
frequency. However, it also increases the size of the focal region
and the likelihood of inertial cavitation that may cause permanent
tissue damage [9]. We have previously shown that intermediate
ultrasound frequencies of 500-kHz allow safe and reversible BBB
opening in non-human primates [10,11]. The resulting wave-
length of 3 mm at this intermediate frequency may provide a good
trade-off between targeting accuracy on the one hand and safety
on the other, without requiring phase aberration correction [12].
Another important challenge in therapeutic ultrasound remains
the need for real-time monitoring and treatment efficiency
verification. It has been shown that a passive cavitation detector
(PCD) can be used to transcranially acquire the acoustic emissions
stemming from the microbubble [13]. The frequency analysis of
the backscattered signal and, more specifically the cavitation dose,
has been proven relevant to characterizing the bubble-capillary
interaction and potential damage in mice along with complete
histological analysis [10,14]. These studies determined acoustic
parameters (in situ pressure, pulse length and pulse repetition
frequency) as well as their PCD signatures for different ultrasound
frequencies and microbubble types in order to ensure safe BBB
opening. Here we propose to extend and upgrade the use of PCD
in order to monitor real-time the BBB opening treatment in non-
human primates.
There are two critical requirements for this technique before
undergoing clinical applications. 1) The procedure needs to be
proven accurate in order to deliver therapeutic agents only in the
desired region of the brain. 2) It also needs to be proven safe. This
encompasses determining a reliable set of acoustic parameters,
monitoring the treatment in real time and understanding the BBB
closing timeline. These questions have been addressed in part for
an MRI-based phased array of ultrasound transducers that was
developed for treatment of brain tumors [15]. Here we address
these questions for our easy-to-use 500-kHz single-element
transducer setup. This is particularly important because the
system operates outside of an MR scanner. Hence, online
monitoring of safety and opening volume in combination with
reliable targeting will further increase independence from MRI-
based targeting and verification of the opening. This manuscript is
meant to pave the way for a long-term study of chronic use of
focused ultrasound BBB opening. The main focus of the work
presented here is about efficacy and targeting and safety studies
are currently ongoing in both mice [16] and monkeys [17].
Methods
Ethics statement
All methods were approved by the Institutional Animal care and
Use Committee at Columbia University and the New York State
Psychiatric Institute. Monkeys had daily interactions with humans
as well as two subjects being paired with each other. All monkeys
were housed in a room with 18 other monkeys on a 12 hour light
dark cycle. Monkeys were fed a diet of vitamin enriched dry
primate biscuits daily and were either provided with 1L of water or
worked for their water via behavioral tasks until they were satiated.
A fruit treat was given to them at the completion of each day along
with various enrichment items including a larger play cage with a
swing. Before being placed in the stereotax for sonications
monkeys were sedated with ketamine for placement of the
intubation tube and IV line and then isofluorane was used to
keep them unconscious during the procedure. No animals were
sacrificed for the purpose of this study.
The ultrasound procedure has been described in greater detail
elsewhere [10,11]. The series of sonications presented in this study
were performed on two male rhesus monkeys (Macaca mulatta)
named O and N. Each animal was treated every two weeks.
Monkeys were positioned in a stereotaxic frame (Figure 1) under
general anesthesia. Sedation was done using ketamine 5–15 mg/
kg IM, and anesthesia was done with isoflurane 1–4% inhaled. A
500-kHz ultrasound transducer was attached to a Kopf stereotaxic
manipulator to enable targeting of the ultrasound focus in
stereotaxic coordinates (see below for details). Once the animal,
the targeting coordinates, and the FUS system were set, negative
control sonications were performed in the absence of micro-
bubbles (see Figure 2 and below for details). After IV injection of
monodispersed 4–5-mm microbubbles that were manufactured in-
house and size-isolated using differential centrifugation [18], the
animals were sonicated for a total duration of 2 minutes with an
estimated focal maximum pressures ranging between 0.20 and
0.30 MPa. Those microbubbles are generally used as ultrasonic
contrast agent and they are evacuated very rapidly from the
system through the lungs and kidneys (half-life time in humans: 5–
10 minutes typically). Post-sonication controls in the presence of
microbubbles were performed immediately after the treatment (see
below for details). Subsequently, the location of the BBB opening
was determined using contrast-enhanced T1 images (see below).
FUS setup
A 500-kHz center frequency focused ultrasound transducer was
used for this experiment (H-107, Sonic Concepts, WA, USA). In
vitro pressure measurements were realized in another study [12].
This study determined the global attenuation (absorption,
reflection and scattering) due to the presence of the skull (around
25.7 dB at 500-kHz). The attenuation in the scalp was assumed to
be around 20.9 dB/cm and its thickness was estimated to be
equal to 0.5 cm. The attenuation in the monkey brain tissue [19]
was assumed to be around 20.5 dB/cm and the thickness of this
layer was estimated to be equal to 2 cm. Therefore, the emission
amplitude was raised by 7.15 dB (approximately a factor of 2.28)
compared to the calibration measurements in water to compensate
for the energy loss along the path. A flatband, spherically focused
hydrophone (Y-107, Sonic Concepts, WA, USA) was positioned
through the center hole of the FUS transducer. The two
transducers were aligned so that their focal regions fully
overlapped within the confocal volume. The hydrophone, which
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was connected to a digitizer (Gage Applied Technologies, Inc.,
Lachine, QC, Canada) through a 20-dB amplification (5800,
Olympus NDT, Waltham, MA, USA), was used to monitor real-
time acoustic emissions from microbubbles (passive cavitation
detection, PCD).
Targeting
To enable individualized targeting of the ultrasound focus to a
particular brain region, T1 weighted stereotaxically aligned
structural images were acquired for all animals (same T1 sequence
as outlined below). For targeting in stereotaxic coordinate frames
we developed an R-based (R Development Core Team 2009)
software package (stereotax.R) that converted a particular setting of
the stereotaxic manipulator (Kopf) into stereotaxic coordinates.
The setting of the stereotaxic manipulator is determined by 9 free
parameters: the setting of the medio-lateral drive (ml), the position
of the manipulator on the stereotaxic arm along the anterior-
posterior direction (ap), the setting of the dorsoventral drive (dv),
the rotation of the manipulator around the z-axis (azimuth), the tilt
of the manipulator (elevation angle) that could occur either around
the ml- or ap-axis (elevation setting), the position of the manipulator
on the left or right stereotaxic arm (arm), the relative alignment of
the ml and dv stereotax drives, i.e., was the ml drive positioned
anterior or posterior to the dv drive (stereo), and finally one degree
of freedom that determined the attachment of the ultrasound
transducer on the stereotaxic manipulator (finger). Based on the
setting of the stereotaxic manipulator, the software predicted the
focal point and the axis from the focal point to the ultrasound
transducer (angle of approach). For visualization purposes, the
predicted region of BBB opening around the ultrasound focus was
then projected onto the individual stereotaxically aligned T1
image (Figure 2). The software also inverted this procedure: for
any desired sonication target (including a desired approach angle)
that can be specified in stereotaxic coordinates, the software
calculated up to eight different setting of the stereotaxic
manipulator that targets this neural structure from the specified
approach angle. The optimal approach angle was determined by
the user. For the experiments reported here, we set the approach
angle to provide a close to perpendicular incidence angle between
ultrasound beam and skull.
Verifying the BBB opening with contrast-enhanced MRI
After sonication, the anesthetized animals were transported to
the MR facility where T2 and T2 FLAIR images were taken to
detect any potential damage caused by the sonication. The
integrity of the BBB was tested using the T1 contrast agent
gadodiamide (OmniscanTM) that is typically used to visualize the
break-down of the BBB in neurological disease [20–22]. To that
aim, a high-resolution structural T1 image was recorded prior to
the injection of gadodimide (T1 Pre; 3D Spoiled Gradient-Echo,
TR/TE=20/1.4 ms; flip angle: 30u; NEX=2; in-plane resolu-
tion: 161 mm2; slice thickness: 1 mm with no interslice gap).
30 min after injection of 0.15 ml/kg gadodiamide IV, another T1
image was acquired using identical scanning parameters (T1 Post).
As gadodiamide does not cross the intact BBB, increased T1 signal
strength will be found in vessels or regions with increased BBB
permeability [20–22]. 3D T2-weighted sequence (TR/
TE=3000/80 ms; flip angle: 90u; NEX=3; spatial resolution:
4006400 mm2; slice thickness: 2 mm with no interslice gap) and
3D Susceptibility-Weighted Image (SWI) sequence were applied
(TR/TE=19/27 ms; flip angle: 15u; NEX=1; spatial resolution:
4006400 mm2; slice thickness: 1 mm with no interslice gap) were
used.
Figure 1. Preclinical setup. Top picture is showing a large view of the operating room. On the right, the PC and amplifiers are used to drive the
transducer-hydrophone assembly. The degassing system (vacuum pump+water circulation pump) ensures a constant flow of degassed water for
acoustic coupling. The transducer-hydrophone assembly is mounted on a manipulator with 5 degrees of freedom (x, y, and z position of the focus, as
well as two approach angles: azimuth and elevation). Bottom picture is depicting a close-up view. The membrane can be inflated regulating the
water flow thanks to the degassing system. This ensures a maximal acoustic transmission in the animal brain.
doi:10.1371/journal.pone.0084310.g001
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Data Analysis
T1 pre and T1 post images were registered to the individual
stereotaxically aligned T1 image using FSL’s FLIRT routine [23].
To estimate gadodiamide concentration [Gd]c we divided the post
T1 image by the pre T1 image (post/pre). The post/pre image
highlights regions of increased T1 contrast following the injection
of gadodiamide. This includes regions of interest where the BBB
was opened, but also any vessels or other regions with high blood
volume such as the pial surface. The post/pre image was then
flipped such that the left hemisphere overlaid the right
hemisphere. The un-flipped image was then divided by the
flipped image. This procedure removed activations due to high
[Gd]c in voxels with high blood-volume, as long as the regions
were symmetric between the hemispheres. The resulting image
that formed the basis of our analysis highlights increased the [Gd]c
in the sonicated region as well as some residual artificial activation
mainly due to the asymmetric vasculature.
To assess the targeting accuracy, the resulting image was rotated
and shifted into a new coordinate frame where the origin was
defined as the predicted location of the ultrasound focus, and the
z-axis corresponded to the approach angle (Figure 3). We selected
a region of interest around the origin corresponding to 67.5 mm
in the x- and y-direction, and 25 to +12 mm along the z-axis. A
voxel was defined as being ‘‘opened’’ when the T1-enhancement
exceeded a threshold of 10%. The total volume of the BBB
opening was quantified as the volume of the opened voxels in the
region of interest around the sonication target. The fraction of
opened voxels was then averaged across the z-axis. Based on this
two-dimensional x-y map, the region of the opening was defined as
pixels with more than an average of 35% of opened voxels (black
contour line). The observed center of the sonication in the x-y-
plane was defined as the center of mass of the region of the
opening (black dot in Figures 4, 5 and 6). The targeting error in
the x-y plane was defined as the difference of the observed position
of the opening from the theoretical position of the geometric focus.
Similarly, targeting accuracy along the axis of propagation of the
ultrasound was assessed by averaging the fraction of opened voxels
across the x- and y-axis. The averaging was restricted to voxels
within a square region of 62 mm around the observed xy-center
of the sonication. The center of the sonication along the z-axis was
defined as the center of gravity of the bins with more than 35%
opened voxels. The targeting error along the z-axis was defined as
the difference between the observed center of the sonication along
the z-axis and the predicted focal depth. The predicted focal depth
was assumed to be the geometric focal depth plus 5 mm due to the
focal shift induced by the skull.
Real-time monitoring
The monitoring technique is based on the evolution of the
frequency content of the backscattered acoustic signal. Because
bubble oscillations along the acoustic excitation are non-linear
(stable cavitation) the PCD will detect harmonic modes in the
frequency spectrum. Bubble collapse and jet, more generally
described as inertial cavitation, induces broadband noise. There-
Figure 2. BBB opening procedure overview. (A&B) Timeline of sonication experiment with subsequent MRI-based verification. Briefly, the
animals are sonicated for two minutes using a 500-kHz focused ultrasound transducer following the systemic injection of microbubbles. The opening
location is then analyzed using contrast-enhanced T1 images (see D for details). Additional clinical scans were performed to detect potential damage.
(C) Geometric ultrasound focus overlaid on a T1 structural scan in stereotaxic coordinate frame. Due to the geometry of the ultrasound transducer,
the focal region is elongated along the axis of ultrasound propagation. Here the ultrasound was applied at an angle of 26u from the upper right to
provide a close to normal incidence angle of the ultrasound and skull. (D) Increased blood-brain barrier (BBB) permeability for the T1 contrast agent
gadodiamide following a single sonication of left caudate. Brighter colors indicate regions where gadodiamide was able to diffuse across the BBB into
the brain tissue. The remaining regions of increased T1 signal indicate asymmetric vasculature. Note the close alignment between intended (C) and
actual location (D) of the BBB opening. The axial shift in location of the BBB opening towards the transducer is close to the value predicted from in-
vitro experiments.
doi:10.1371/journal.pone.0084310.g002
Real-Time Monitoring of Barrier Opening
PLOS ONE | www.plosone.org 4 February 2014 | Volume 9 | Issue 2 | e84310
fore, detection of broadband response is the signature of inertial
cavitation. A previous study [14] has shown that using 4–5- mm
monodispersed microbubbles, inertial cavitation was not required
to open the BBB. Also, stable cavitation alone has never been
associated with any tissue damage [14]. The frequency spectra of
backscattered acoustic emissions were used to infer the cavitation-
behavior of the micro-bubbles in the focal region. In order to
remove the harmonic (nf, n = 1, 2, …,6), sub-harmonic (f/2) and
ultra-harmonic (nf/2, n= 3, 5, 7, 9) frequencies produced by stable
cavitation [12], the response within a 300-kHz bandwidth around
each harmonic and 100-kHz bandwidth of each sub- and ultra-
harmonic frequency were filtered out in order to obtain the
broadband signal. This was performed within the 0.6–5.2 MHz
frequency band in order to avoid perturbation induced by the
fundamental frequency and to take in to account the growing
attenuation of the signal along the frequency. From those sets of
two spectra, both the broadband and total energies (respectively
ebroadband and etotal) are computed by summing the spectral





Two metrics are then defined as indications of inertial or stable
cavitation by analyzing the differences between backscattered with
and without bubbles. The broadband energy increase (BEI) from
the negative control level (without microbubbles) was monitored as





The harmonic energy is obtained by subtracting the broadband
energy to the total energy. The harmonic energy increase (HEI) is









The energy increase of the control signals were defined as the
average value of the 2 second long negative control sonication that
was taken right before injecting the bubbles but otherwise used the
exact same ultrasound parameters as the treatment sonication.
Immediately after the treatment sonication, a series of 2-sec
positive control sonications were performed while microbubbles
were still in circulation. The positive controls used pressures
between 0.05 and 0.35 MPa. Except for the shorter duration and
variable pressures, they used the exact same sonication settings
that were applied for the treatment sonication. The aim of the
positive controls was to describe the relationship between
ultrasound pressure and the harmonic/broadband energy in-
crease. There were 8 testing sets done in the study. We calculated
the mean HEI over the entire sonication to relate stable cavitation
to the observed size of the BBB opening.
Results
This study reports the results of a series of 17 sonications
targeting the caudate nucleus (6) and the putamen (11) in the left
hemispheres of two macaque monkeys. The analyses are focused
on targeting accuracy, the relationship between PCD response and
BBB opening volume as well as safety of the procedure. In
addition, one exploratory study examined the duration for which
the BBB remains open after the sonication.
Targeting Accuracy
Figure 2 shows a typical result of BBB disruption using T1-
weighted MR imaging and gadodiamide MR contrast agent. The
image on the left depicts the theoretical position of the ultrasound
Figure 3. Quantification of targeting accuracy. After calculating the raw result image that provides a normalized estimate of the increase in T1
contrast (A), the image is shifted and rotated in to a new coordinate frame (B) whose origin is defined by the coordinates of the intended target, and
the z-axis corresponds to the approach angle. A voxel is considered opened if its T1 value was enhanced by $10%. The in-plane targeting accuracy
was assessed by averaging the fraction of opened voxels across the z-axis (C). Targeting in the depth axis along the ultrasound beam was quantified
by collapsing across the x- and y-axis (D).
doi:10.1371/journal.pone.0084310.g003
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focus. The image on the right renders regions where the T1
contrast agent gadodiamide was able to diffuse to the brain
parenchyma as a result of BBB opening (see Methods for details).
This figure highlights the good qualitative agreement between the
intended target of the ultrasound focus and the actual region of
increased BBB permeability.
In order to quantify the targeting accuracy of the method, the
processing described in Figure 3 was performed for each
experiment (see Methods). The individual plots for lateral and
axial targeting accuracy are depicted in Figure 4 for caudate
targets of both animals. Figures 5 and 6 provide identical plots for
the putamen sonications in the two animals, respectively. These
results prove the reproducibility and targeting precision of the
FUS technique. First, we quantified the targeting accuracy by
averaging the relative focal position for all sonications and
animals. The mean focal point was 0.261.0 mm posterior to the
intended target (all results are reported as mean6standard
deviation in mm). This difference did not reach significance (t-
test, p.0.05). The observed focal point was significantly ventral to
the intended target (1.961.7 mm; t-test p,0.05). Further, the
mean focal point was significantly shifted towards the ultrasound
transducer (1.461.4 mm, t-test, p,0.05). It is important to note
that predicted focal depth was defined as the depth of the
geometric ultrasound focus plus 5 mm (i.e., shifted towards the
ultrasound transducer). The 5 mm shift was added to account for
the shift of focal depth that was measured in vitro with immersed
skull plates [12]. Hence, our results demonstrate the close
correspondence between the in vitro and in vivo measurements.
However, they imply a somewhat stronger focal shift was observed
in our in vivo experiments.
The reliability of the sonication procedure was assessed as the
mean targeting error (absolute distance from intended target). The
mean targeting error over all sonications in the lateral plane was
2.561.2 mm. Mean targeting error in the axial direction was
1.561.3 mm. Combined lateral and axial error averaged
3.161.3 mm.
We further tried to dissociate random errors due to day-to-day
fluctuations from systematic targeting errors that could be specific
to a particular animal and/or target. To quantify the systematic
targeting error we averaged the location of the focal point for both
targets and both animals separately. The mean systematic lateral
targeting error was 1.8 mm. Mean systematic axial targeting error
Figure 4. Targeting accuracy for 6 (4+2 for two monkeys O and N) sonications of caudate nucleus. The panels in the first row show the
color-coded fraction of activated voxels (.10% enhancement of T1 signal) as a function of medio-lateral and antero-posterior deviation from the
intended focal point in the x-y-plane. The panels collapse across voxels that are between 25 and 10 mm in depth from the intended depth. In all
instances the opening of the BBB either overlaps with or is in immediate vicinity of the intended target. To quantify targeting accuracy along the
direction of the ultrasound propagation, panels in the second row show the fraction of activated voxels collapsed around a 2 by 2 mm square region
around the measured focal point (block dots in panels in A). The dotted horizontal line corresponds to the depth of the geometric ultrasound focus.
As predicted from in-vitro experiments, the actual focal depth (solid horizontal line) is shifted ,5 mm towards the ultrasound transducer. Panels in
the third row depict the backscattered acoustic energy of the microbubbles excited in the ultrasound focus as a function of time from injection of the
microbubbles. The blue line to the desired harmonic oscillations of the microbubbles (HEI) that have been associated with safe BBB opening. The
black line corresponds to inertial cavitation (BEI) that has been linked to extravasation of red blood cells and tissue damage. The red line corresponds
to the BEI detection threshold.
doi:10.1371/journal.pone.0084310.g004
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was 1.4 mm. Combining the lateral and axial error we observed a
mean systematic targeting error of 2.7 mm across all four targets (2
targets in 2 animals). We used an analysis of variance to test
whether targeting accuracy differs as a function of the four
different groups of sonications (two targets in two animals). Neither
anterior-posterior nor axial position (relative to the intended
target) differed as a function of the sonication group. However, we
found that dorso-ventral position depended on sonication group
(ANOVA, p,0.05). This effect is most likely due to the difference
between the two caudate and the two putamen targets. In both
animals, the sonications to putamen exhibited a systematic
targeting error in the along the dorso-ventral axis. No such
systematic targeting error was found in the caudate sonications.
We further quantified the random error, i.e., the absolute
distance of the observed focus from the mean focal point over all
repetitions with the same target in the same animal. The mean
random lateral error was 1.260.6 mm. The mean random axial
error was 0.660.6 mm. Combining lateral and axial error we find
a mean random error of 1.560.7 mm.
We then quantified the size of the region in which the
permeability of the BBB was increased. Averaged over all
sonications, the volume of the BBB opening was estimated at
115644 mm3. Larger openings were observed at higher sonica-
tion pressures (0.30 MPa, Figure 8A). Moderate openings were
observed at lower pressures (0.20 or 0.25 MPa). One sonication at
0.25 MPa failed to elicit any opening (Figure 5). Another
sonication at 0.20 MPa only elicited a minimal opening (Figure 4).
Real-time PCD monitoring
HEI and BEI monitoring were performed for each experiment
in real time. The lower rows in Figures 5–7 render the recorded
real-time monitoring for the corresponding sonications. In all but
one of the sonications, HEI increased by at least 15 dB during the
sonication. This is indicative of stable cavitation of the bubbles in
the focal region. The lack of an increase in broadband energy
indicates the absence of potentially harmful inertial cavitation. A
6 dB threshold, corresponding approximately to two times average
of the negative controls, had been set as a limit of potential
damage and was never surpassed.
To characterize the dynamic range of the HEI and BEI
responses, we measured acoustic emissions as a function of
ultrasound pressure using a series of brief ultrasound pulses of a
wide range of pressures (see Methods). Figure 7 shows HEI and
BEI as a function of ultrasound pressure. As expected, the HEI
starts increasing for lower pressures (0.15 MPa). In contrast, the
BEI remains unchanged at 0 dB for pressures up to 0.35 MPa.
The HEI seems to reach an asymptote of approximately 10 dB for
pressures at and above 0.25 MPa. It is lower than what is shown in
the real-time PCD monitoring since this PCD testing was done
after the treatment sonication and part of the circulating bubbles
were degraded. This analysis defines a window between 0.15 and
0.35 MPa that leads to a reliable increase of harmonic energy
while avoiding potentially harmful broad-band energy increase. In
this study, pressures were well within this window and ranged
between 0.20 and 0.30 MPa.
Figure 5. Targeting accuracy and PCD responses for 6 sonications of putamen in animal one. Conventions as in Figure 4. The PCD for
sonication 12 06 23 shows immediately elevated HEI values because by accident, the microbubbles were injection before sonication onset.
doi:10.1371/journal.pone.0084310.g005
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We then tested whether the online PCD monitoring can be used
to predict the success of the sonication and the size of the ensuing
BBB opening. To that aim we plotted size of the BBB opening as a
function of the mean HEI during the 2-minute sonication period
(Figure 8B). Our results show that stronger HEI responses are not
indicative of larger BBB opening volume. However, in all but two
cases, the presence of HEI went along with a successful BBB
opening.
Safety
Additional MR imaging sequences (T2-weigthed and SWI, see
Methods) were used to assess potential brain damage after the
ultrasound procedure. In line with the observed stable cavitation
that is indicative of safe in situ ultrasound pressures, neither T2
nor SWI images detected any damage such as edema or
hemorrhage in all experiments reported in this paper. Figure 9
shows coronal slices of T2-weighted and SWI images correspond-
ing to the T1-weigthed coronal slices rendered in Figure 2.
Qualitatively, we did not notice any post-procedure clinical deficits
in activity level, movement or feeding/appetite. As no animal was
sacrificed, there was no histological assessment of tissue damage.
Closing timeline
A preliminary experiment to investigate the closing timeline was
also performed. As a first step we measured the time course of the
BBB closing for a single sonication in one of the macaque subjects.
Gadodiamide IV injections along with pre- and post-T1-weighted
MR sequences were repeated 1, 2 and 4 days after the initial
ultrasound treatment. Coronal and sagittal slices of these
experiments can be seen in Figure 10. Standard T1 contrast
enhanced imaging and subsequent analyses indicate a clearly
visible, average-sized (126 mm3) BBB opening. Figure 11 shows
the opening volume decreased with time. The BBB was almost
completely restored two days after sonication. Experiments in mice
have shown that the duration of the BBB opening depends on
acoustic and microbubble parameters [24].
Figure 6. Targeting accuracy and PCD responses for 5 sonications of putamen in the second animal. Conventions as in Figure 4.
doi:10.1371/journal.pone.0084310.g006
Figure 7. Harmonic (HEI) and broadband (BEI) energy increase
plotted as a function of ultrasound pressure. Data was acquired
using a series of brief pulses of ultrasound after the main sonication
while micro-bubbles were still circulating. The blue dash line
corresponds to the lowest pressure at which BBB opening was
achieved, and the. The light blue area highlights the pressure range
used in this study. The red line corresponds to the ultrasound pressure
that would cause BEI to rise above levels that were found to be safe in
the current set of sonications.
doi:10.1371/journal.pone.0084310.g007
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Discussion
The experiments presented in this paper were aimed at testing
whether a single spherical transducer at an intermediate frequency
of 500-kHz can be used for accurate, repeatable and localized
blood-brain barrier disruption in deep subcortical structures. The
observed targeting error was sufficiently small (2.561.2 mm
laterally, 1.561.3 mm along depth-axis, 3.161.3 mm total) to
enable the specific targeting of substructures of the basal ganglia
such as the associative or oculomotor caudate. These findings are
consistent with and extend our previous in vitro and preliminary in
vivo findings [10,12]. This technique might be suitable for precise
drug delivery applications into different brain structures. The
average volume of the BBB opening was estimated at
115644 mm3. As a comparison, the putamen has an approximate
volume of 494.8 mm3 and the caudate of 451.4 mm3 [25].
Sources of targeting errors
To further reduce the targeting error it is important to analyze
potential sources of the error. Here we will briefly discuss three
potential factors: errors due to deviation of the geometric focus
from the intended target (geometric errors), errors due to the
analysis of the focal position (analysis errors), and errors due to
deviation of actual ultrasound focus from the geometric focus
(ultrasound aberration errors). We will argue that most of the
overall error is geometric or analysis errors.
Geometric errors. Over the course of the experiments, we
repeatedly calibrated the stereotaxic manipulator and the targeting
routine. For these calibrations we used a metal rod that was
attached to the stereotaxic manipulator in the same way as the
ultrasound transducer. The length of the rod was chosen to match
the focal length of the transducer and hence its tip corresponded to
the location of geometric ultrasound focus (assuming there were no
ultrasound aberrations). This setup enabled us to target various
know positions, such as the interaural point of the stereotax. These
measurements routinely found deviations from the intended target
on the order of 1–2 mm. Geometric error arises when the setting
on the stereotaxic manipulator that determines geometric focus is
off. The position of the geometric focus is determined by the 9
degrees of freedom of the stereotaxic manipulator. Some of these
settings are continuous and prone to error. The ml, ap, and dv
settings have 1 mm scales in combination with a vernier scale to
enable accuracy on the order of a tenth of a millimeter. The
azimuth and elevation scales, however, are divided in steps of 5
and 2 degrees, respectively, without an additional vernier scale.
Figure 8. BBB opening volume as a function of pressure (A) and the average harmonic energy increase, HEI (B). Two targets in the
putamen and the caudate for two animal subjects (O and N) were marked separately. (A) There is a clear relationship between ultrasound pressure
and opening size (r = 0.41). Due to the narrow range of pressures and low number of sonications, this effect does not reach significance. (B) There is
no apparent relationship between average HEI and opening volume.
doi:10.1371/journal.pone.0084310.g008
Figure 9. Example of T2-weighted (left) and SWI (right) MR
images corresponding to the experiment from Figure 2. Edemas
should appear brighter in T2-weighted images; hemorrhages, as well as
large vessels should appear in black in SWI images. No damage was
detected on any of the experiments performed.
doi:10.1371/journal.pone.0084310.g009
Figure 10. Coronal (left row) and sagittal (right row) T1-
weighted MR slices showing the evolution of the BBB opening
volume along time. The area with contrast agent diffusion is overlaid
in blue. The BBB is restored between day 2 and 4.
doi:10.1371/journal.pone.0084310.g010
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This enables accuracy on the order of 1 to 2 degrees. Even small
angular deviations may have a big effect on the final position of the
geometric focus.
The elevation setting is critical an additional reason: If the
approach angle deviates from vertical, gravitational forces
perpendicular to the approach angle will grow stronger. These
gravitational forces may introduce systematic errors for angled
approach vectors. It is interesting to note that the mislocalization
in the dorso-ventral direction was strongest for the putamen target,
and that this target required a more angled approach. Note that
the ventral mislocalization decreases over time (Figure 7 and 8).
This may reflect the fact that over the time-course of the
experiments reported here we learned to use more force to fasten
the set-screws that are responsible to maintain the elevation angle
against gravitational pull.
Analysis errors. Further, it is important to point out that
analysis pipeline used to infer the observed focal point may induce
additional small errors. The analysis depends on alignment of pre-
and post contrast-enhanced T1 images to a stereotaxically aligned
reference image. Small errors may arise during the registration
process of the pre- and post images to the reference. Similarly the
alignment of the reference image may not perfectly match the
intended stereotaxic alignment. In addition, the actual position of
the animal in the stereotax may vary slightly on a day-by-day
basis. Together these factors could contribute up to 1 mm of the
random and/or systematic targeting error. Further, the fractional
enhancement of the post- relative to the pre- image is based on
noisy T1 MRI images. While it is difficult to quantify, this factor
will certainly contribute to the overall targeting error.
Ultrasound aberration errors. The above data and anal-
yses argue that most of the error may easily be explained by
geometric and analysis factors. However, mislocalization in the
axial direction is known to occur due to ultrasound aberrations
based on in-vitro measurements with immersed skull plates [12].
Our findings closely replicate the in vitro findings. On average we
observed a 6.5 mm focal shift, compared to the predicted 5 mm
focal shift. At this point it is not clear if the additional 1.5 mm are
due to different ultrasound aberrations in vivo or if they are due to
geometric and analysis error.
Real-time PCD monitoring
Real-time monitoring based on the frequency content of the
backscattered signal was performed to classify the cavitation
behavior and hence establish the success and safety of the
sonication. Measuring the cavitation spectrum is helpful to verify
that the microbubbles are correctly excited in situ, i.e., non-linear
resonance along the ultrasonic frequency without broadband noise
signature of bubbles collapsing or micro-jet streaming (inertial
cavitation). This translates into a significant HEI (between 15 dB
and 25 dB) and no BEI. During all experiments performed in this
paper (pressures at or below 0.3 MPa) only stable cavitation was
observed. Therefore, the PCD monitoring indicated that the
procedure would be safe and successful. Also, the HEI has been
found to be indicator of the success of the BBB opening in these
initial findings. For the cases with an average HEI higher than
5 dB, there was 94% (15/16) of success. The correlation between
the HEI and the opening volume in Figure 8B was not high since
we focused on a small range of pressures (0.20–0.30 MPa). It
might be a more reliable predictive metric if the correction of the
skull attenuation could be made.
Future directions
MRI-independent targeted BBB opening. Focused ultra-
sound can be used to temporarily disrupt the integrity of the blood
brain-barrier in specifically targeted brain regions of rodents and
monkeys. In the near future, focused ultrasound may allow
clinicians to deliver drugs to specific neural targets. However,
current clinical ultrasound setups comprise multi-phased ultra-
sound transducer arrays located inside an MR scanner. This
restricts the use of ultrasound to highly specialized clinical settings.
Here we use a low-tech single-element 500-kHz spherical
transducer ultrasound setup that has the potential to overcome
this limitation. The system was specifically designed in principle to
be portable, and uses a stereotaxic targeting procedure to make it
independent of MR guided targeting. The current paper
addressed two essential questions to verify that the system can
indeed be used independent of an MR scanner. First, we have
shown that the stereotaxic targeting procedure is accurate and
reliable. Second, we tested whether the success of the sonication
can reliably be inferred using real-time passive cavitation spectral
analysis. While successful sonications were almost always accom-
panied by a 10–15 dB HEI, we found no correlation between HEI
and opening volume. Additional experiments are needed to
establish a closer link between the PCD monitoring and the
outcome of the sonication.
In summary, these findings show that our portable system can
safely and reliably be used to open the BBB in specific brain
regions of the macaque monkey, largely independent of MRI-
guided targeting and/or verification. Hence, in principle, this
system has the potential to provide non-invasive targeted brain-
drug delivery to a broad patient base in less specialized clinical
settings (e.g., outpatient clinics; community hospitals). It is of
course important to note that targeting accuracy can be increased
by using an individual stereotaxically aligned T1 image. This,
however, constitutes a one-time procedure and all following
sonications would be completely independent of MRI.
Time-course of BBB closing. The ultimate goal of the
ultrasound method is to deliver pharmacological agents to
specifically targeted neural substrates. The results and analyses
Figure 11. Timeline of BBB closing for a single low-pressure
sonication depicted in Figure 10. Voxels with a normalized pre-post
enhancement of more than 10% were classified as ‘‘opened’’. The total
volume of opened voxels decreases as a function of time from the
sonication. The opened volume in the contra-lateral control region is
constant and close to the one predicted by a false detection rate of 5%.
doi:10.1371/journal.pone.0084310.g011
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outlined above show that the single-element FUS method can be
used to accurately and reliably target sub-structures of the basal
ganglia. However, there still remain a number of questions that
need to be answered before the method can be used to deliver
drugs to those neural targets in human subjects. In particular, it is
still not known how long the BBB will stay open before it
regenerates and prevents the passage of molecules from the blood
to the brain. This is important for two reasons: First, this
determines the window of opportunity during which drugs can be
delivered. On the other hand, this determines how long the brain
region in question will be exposed to other substances that usually
would not cross the intact BBB. Previous studies in mice have
indicated that the duration of the BBB opening depends on the
precise sonication parameters such as ultrasound pressure and
microbubble size. The duration of the BBB opening can range
between 12 hours and 5 days [24]. However, to date it is not
known whether the same relationship between ultrasound
parameters and BBB opening duration also holds for human
subjects. Due to the closer similarity between brain structures of
the two species, these measurements may provide a more accurate
idea about what time course to expect in the human brain. The
results from a single exploratory analysis indicated that an
average-sized BBB opening (,126 mm3) with moderate in situ
ultrasound pressures (0.30 MPa) and 4–5-mm monodisperse
microbubbles takes between 2 and 4 days to close. This finding
is in agreement with previous work performed in mice [24].
However, a more thorough set of experiments is needed to verify
the inter-species agreement over a wider set of parameters.
Safety of repeated sonications and drug delivery
As stated in the introduction, ongoing chronic studies are being
performed on both mice and monkeys. These studies will include
safety investigation of repeated openings over 6 months in mice
[16] and complete behavioral testing in monkeys [17]. Future
studies will also been needed to determine whether therapeutically
relevant levels of the drugs can be maintained after crossing the
BBB.
Conclusion
The findings of this study demonstrated that a single spherical
transducer operating at an intermediate frequency of 500-kHz can
be used for accurate, repeatable and localized blood-brain barrier
disruption in deep subcortical structures. This constitutes an
important first step towards developing a non-invasive targeted
drug-delivery system. This method shows unique potential for
clinical treatments of neurodegenerative diseases and also for
neuroscientists, who aim at dissecting the function of deep regions
of the brain such as the basal ganglia. Real-time monitoring was
developed and may be a trustworthy safety measure during BBB
opening. Preliminary results show that using our typical set of
acoustic parameters, the integrity of the BBB was restored after
approximately two days.
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